
MeiraGTx Holdings plc MGTX
$ 7.61
0.6%
Quarterly report 2025-Q3
added 11-13-2025
MeiraGTx Holdings plc Total Non Current Liabilities 2011-2026 | MGTX
Annual Total Non Current Liabilities MeiraGTx Holdings plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 83.9 M | 336 K | 51.8 M | 33.6 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 83.9 M | 336 K | 42.4 M |
Total Non Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
40.2 M | - | 2.43 % | $ 254 M | ||
|
Xeris Pharmaceuticals
XERS
|
97.2 M | $ 6.03 | -1.55 % | $ 885 M | ||
|
I-Mab
IMAB
|
131 M | - | - | $ 866 M | ||
|
UroGen Pharma Ltd.
URGN
|
4.21 M | $ 19.2 | -11.52 % | $ 554 M | ||
|
uniQure N.V.
QURE
|
563 M | $ 10.89 | -30.36 % | $ 530 M | ||
|
GT Biopharma
GTBP
|
714 K | $ 0.47 | -2.41 % | $ 892 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
4.83 B | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
2.02 M | - | -13.47 % | $ 169 M | ||
|
AbCellera Biologics
ABCL
|
326 M | $ 3.74 | 3.6 % | $ 1.12 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
6.39 M | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
110 K | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
27.3 M | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
541 M | - | - | - | ||
|
ARCA biopharma
ABIO
|
409 K | - | 1052.0 % | $ 415 M | ||
|
Acer Therapeutics
ACER
|
244 K | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
15.9 M | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
257 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
12.2 M | - | 4.01 % | $ 150 M | ||
|
CureVac N.V.
CVAC
|
112 M | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
19.1 M | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
1.53 M | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
4.74 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
4.15 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
2.29 M | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
264 M | $ 3.36 | 0.86 % | $ 1.2 M | ||
|
Ayala Pharmaceuticals
AYLA
|
553 K | - | - | $ 7.46 M | ||
|
Akero Therapeutics
AKRO
|
1.52 M | - | - | $ 3.67 B | ||
|
Agios Pharmaceuticals
AGIO
|
157 M | $ 29.16 | -3.54 % | $ 1.69 B | ||
|
Advaxis
ADXS
|
16 M | - | -9.65 % | $ 45.9 M | ||
|
Akouos
AKUS
|
12 M | - | 0.23 % | $ 488 M | ||
|
Завод ДИОД
DIOD
|
89.5 M | - | - | - | ||
|
Фармсинтез
LIFE
|
13.2 M | - | - | - | ||
|
Albireo Pharma
ALBO
|
79.1 M | - | -0.23 % | $ 916 M | ||
|
Alector
ALEC
|
165 M | $ 2.19 | -9.77 % | $ 226 M | ||
|
Entera Bio Ltd.
ENTX
|
324 K | $ 1.38 | -0.72 % | $ 63.3 M | ||
|
Allena Pharmaceuticals
ALNA
|
10.2 M | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
4.59 M | - | 10.36 % | $ 9.8 M | ||
|
Altimmune
ALT
|
5.33 M | $ 4.21 | -2.32 % | $ 299 M | ||
|
Teligent, Inc.
TLGT
|
142 M | - | -13.85 % | $ 16.1 M | ||
|
AlloVir
ALVR
|
5.46 M | - | 4.14 % | $ 49.1 M | ||
|
Evogene Ltd.
EVGN
|
5.36 M | $ 0.84 | -4.24 % | $ 27.9 M | ||
|
Viela Bio, Inc.
VIE
|
1.38 M | - | - | $ 2.91 B | ||
|
Ampio Pharmaceuticals
AMPE
|
3.53 M | - | -11.43 % | $ 502 K | ||
|
Amarin Corporation plc
AMRN
|
31.7 M | $ 13.98 | 1.27 % | $ 5.7 B | ||
|
AbbVie
ABBV
|
81.7 B | $ 233.57 | 0.64 % | $ 413 B | ||
|
Blueprint Medicines Corporation
BPMC
|
137 M | - | - | $ 8.14 B | ||
|
Applied Molecular Transport
AMTI
|
106 M | - | - | $ 10.1 M | ||
|
AIM ImmunoTech
AIM
|
6.18 M | $ 0.8 | -11.6 % | $ 38.5 M | ||
|
Aptorum Group Limited
APM
|
2.21 M | $ 0.83 | 5.37 % | $ 4.53 M | ||
|
Apellis Pharmaceuticals
APLS
|
289 M | $ 20.67 | -1.38 % | $ 2.61 B |